Zhen Zhang

This inventor holds 17 USPTO granted patents and 14 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Johns Hopkins University, Horus Therapeutics, Inc., Vermillion Corporation. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhen Zhang. Retrieved from https://idiyas.com/inventor/zhen-zhang-fa5tsfro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 14)

% Patents Active = 88.2

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.2

ph-index = 8

Forward Citations = 776(Granted Patents)

Location History:

Mt. Pleasant, SC (US) (1998 - 2001)
Baltimore, MD (US) (2022)
Dayton, MD (US) (2006 - 2024)

Company Filing History:

11 out of 3,801

Johns Hopkins University

patents

4 out of 4

Horus Therapeutics, Inc.

patents

4 out of 26

Vermillion Corporation

patents

4. 1 out of 1

Aspira Women's Health Inc.

The University of Texas System

8. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448654 - Compositions and methods for detecting pancreatic cancer (2025-10-21),

2. 12037647 - Compositions and methods for detecting pancreatic cancer (2024-07-16),

3. 11255857 - Biomarkers for ovarian cancer CTAP3-related proteins (2022-02-22),

4. 10877046 - Treatment of spontaneous preterm birth (2020-12-29),

5. 9816995 - Biomarker for ovarian cancer CTAP3-related proteins (2017-11-14),

6. 9551703 - High precision quantitative assay composition and methods of use therefor (2017-01-24),

7. 8682591 - Biomarkers for ovarian cancer (2014-03-25),

8. 8603734 - Biomarkers for prostate cancer (2013-12-10),

9. 8440409 - Protein C inhibitor as a biomarker for prostate cancer (2013-05-14),

10. 7951529 - Biomarkers for breast cancer (2011-05-31),

11. 7605003 - Use of biomarkers for detecting ovarian cancer (2009-10-20),

12. 7510842 - Biomarker for ovarian and endometrial cancer: hepcidin (2009-03-31),

13. 7113896 - System and methods for processing biological expression data (2006-09-26),

14. 6309816 - Methods for diagnosing cancer by measuring creatine kinase (2001-10-30),

15. 6306087 - Computer assisted methods for diagnosing diseases (2001-10-23),

Title: Inventor Zhen Zhang: Pioneering Innovations in Dayton

Introduction: Zhen Zhang, a distinguished inventor based in Dayton, MD, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Zhen Zhang holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more efficient and eco-friendly future.

Career Highlights: With a career spanning over two decades, Zhen Zhang has worked with leading research institutions and technology companies to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Zhen Zhang has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life, fostering a culture of creativity and excellence in the field of invention.

Conclusion: Zhen Zhang's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Dayton and beyond.

Profile summary based on public USPTO records.